Methylprednisolone Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials
• Forums

Ruxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myeloma
WEST HOLLYWOOD, Calif., Dec. 20, 2022, ONCOtherapeutics and Dr. James Berenson published promising new data demonstrating that ruxolitinib (RUX), an oral JAK1/2 inhibitor, with only methylprednisolone (MP) well tolerated and shows efficacy for... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 20, 2022 Category: Pharmaceuticals Source Type: clinical trials

Distal Radius Steroid
Conditions:   Fractures, Bone;   Fractures, Closed;   Radius Fracture Distal Interventions:   Drug: Dexamethasone;   Drug: Methylprednisolone;   Other: Standard of Care Sponsor:   Indiana Hand to Shoulder Center Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials